Rank | Gene Set | Z-score |
---|---|---|
1 | cardiac myofibril assembly (GO:0055003) | 9.96887175 |
2 | sarcomere organization (GO:0045214) | 9.86183704 |
3 | myofibril assembly (GO:0030239) | 8.68572741 |
4 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 8.59931766 |
5 | * actin-myosin filament sliding (GO:0033275) | 8.22920418 |
6 | * muscle filament sliding (GO:0030049) | 8.22920418 |
7 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 7.90050973 |
8 | cardiac muscle cell development (GO:0055013) | 7.35772525 |
9 | cardiac muscle contraction (GO:0060048) | 7.32607264 |
10 | skeletal muscle contraction (GO:0003009) | 7.12619936 |
11 | cardiac cell development (GO:0055006) | 6.92198359 |
12 | * actin-mediated cell contraction (GO:0070252) | 6.82236260 |
13 | * cardiac muscle tissue morphogenesis (GO:0055008) | 6.63253735 |
14 | * ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 6.58469646 |
15 | actomyosin structure organization (GO:0031032) | 6.53624776 |
16 | cardiac muscle hypertrophy (GO:0003300) | 6.32509844 |
17 | * adult heart development (GO:0007512) | 6.18631033 |
18 | plasma membrane repair (GO:0001778) | 6.13566190 |
19 | negative regulation of cardiac muscle cell apoptotic process (GO:0010667) | 6.12468108 |
20 | regulation of actin filament-based movement (GO:1903115) | 6.03045545 |
21 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 6.00995380 |
22 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 5.98351094 |
23 | striated muscle hypertrophy (GO:0014897) | 5.98032779 |
24 | regulation of sarcomere organization (GO:0060297) | 5.95330850 |
25 | ventricular cardiac muscle cell action potential (GO:0086005) | 5.93751270 |
26 | * muscle tissue morphogenesis (GO:0060415) | 5.88892473 |
27 | heart trabecula formation (GO:0060347) | 5.83554227 |
28 | creatine metabolic process (GO:0006600) | 5.71800502 |
29 | heart process (GO:0003015) | 5.66579021 |
30 | heart contraction (GO:0060047) | 5.66579021 |
31 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 5.57186883 |
32 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 5.57006960 |
33 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 5.50523094 |
34 | * striated muscle contraction (GO:0006941) | 5.48464551 |
35 | tricarboxylic acid cycle (GO:0006099) | 5.45733147 |
36 | response to inactivity (GO:0014854) | 5.44928241 |
37 | negative regulation of striated muscle cell apoptotic process (GO:0010664) | 5.44116522 |
38 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 5.41994674 |
39 | regulation of cardioblast differentiation (GO:0051890) | 5.33698499 |
40 | muscle hypertrophy (GO:0014896) | 5.31609369 |
41 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 5.29330553 |
42 | regulation of striated muscle contraction (GO:0006942) | 5.17015234 |
43 | * actin filament-based movement (GO:0030048) | 5.15225137 |
44 | regulation of relaxation of muscle (GO:1901077) | 5.12156279 |
45 | NADH metabolic process (GO:0006734) | 5.10759651 |
46 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 4.96606143 |
47 | muscle hypertrophy in response to stress (GO:0003299) | 4.96606143 |
48 | cardiac muscle adaptation (GO:0014887) | 4.96606143 |
49 | regulation of skeletal muscle contraction (GO:0014819) | 4.91865235 |
50 | ventricular cardiac muscle cell development (GO:0055015) | 4.90467462 |
51 | * regulation of the force of heart contraction (GO:0002026) | 4.88717445 |
52 | response to muscle activity (GO:0014850) | 4.86143459 |
53 | regulation of membrane repolarization (GO:0060306) | 4.83738810 |
54 | negative regulation of protein localization to cell surface (GO:2000009) | 4.79669021 |
55 | cell communication involved in cardiac conduction (GO:0086065) | 4.73177105 |
56 | cell communication by electrical coupling (GO:0010644) | 4.70484463 |
57 | carnitine shuttle (GO:0006853) | 4.48159950 |
58 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 4.25956236 |
59 | negative regulation of potassium ion transport (GO:0043267) | 4.25822320 |
60 | regulation of striated muscle cell apoptotic process (GO:0010662) | 4.22409800 |
61 | cardiac chamber formation (GO:0003207) | 4.18791939 |
62 | cardiac muscle cell action potential (GO:0086001) | 4.16585067 |
63 | regulation of cardiac muscle contraction (GO:0055117) | 4.16330770 |
64 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 4.15989243 |
65 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.11670956 |
66 | striated muscle cell development (GO:0055002) | 4.10919078 |
67 | atrial septum morphogenesis (GO:0060413) | 4.10655159 |
68 | regulation of ATPase activity (GO:0043462) | 4.08749134 |
69 | regulation of ATP catabolic process (GO:1903289) | 4.08749134 |
70 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 4.07779786 |
71 | skeletal muscle adaptation (GO:0043501) | 4.01648224 |
72 | regulation of cell communication by electrical coupling (GO:0010649) | 4.00438808 |
73 | * regulation of heart rate (GO:0002027) | 3.99874701 |
74 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.96964314 |
75 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.96964314 |
76 | trabecula formation (GO:0060343) | 3.95964379 |
77 | muscle fiber development (GO:0048747) | 3.86678109 |
78 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.84904274 |
79 | ATP synthesis coupled proton transport (GO:0015986) | 3.84904274 |
80 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.84198079 |
81 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 3.83932749 |
82 | regulation of cardiac muscle cell apoptotic process (GO:0010665) | 3.82243076 |
83 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 3.81385729 |
84 | * regulation of heart contraction (GO:0008016) | 3.79305116 |
85 | fatty acid transmembrane transport (GO:1902001) | 3.73130225 |
86 | outflow tract septum morphogenesis (GO:0003148) | 3.72222279 |
87 | regulation of cardiac muscle cell contraction (GO:0086004) | 3.71701053 |
88 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 3.69932843 |
89 | skeletal muscle fiber development (GO:0048741) | 3.69679200 |
90 | 2-oxoglutarate metabolic process (GO:0006103) | 3.67387573 |
91 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.66571849 |
92 | relaxation of cardiac muscle (GO:0055119) | 3.66505237 |
93 | regulation of heart rate by cardiac conduction (GO:0086091) | 3.65787499 |
94 | regulation of muscle system process (GO:0090257) | 3.62522753 |
95 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 3.62098906 |
96 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 3.62098906 |
97 | regulation of muscle contraction (GO:0006937) | 3.61235138 |
98 | cardiac ventricle formation (GO:0003211) | 3.60177892 |
99 | cardiac conduction (GO:0061337) | 3.57685898 |
100 | striated muscle adaptation (GO:0014888) | 3.55138935 |
101 | muscle cell development (GO:0055001) | 3.54606708 |
102 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.51527394 |
103 | negative regulation of myotube differentiation (GO:0010832) | 3.50357568 |
104 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 3.50310400 |
105 | regulation of sequestering of triglyceride (GO:0010889) | 3.49417382 |
106 | potassium ion export (GO:0071435) | 3.47105622 |
107 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 3.47050966 |
108 | myotube cell development (GO:0014904) | 3.46980545 |
109 | muscle adaptation (GO:0043500) | 3.46174404 |
110 | response to caffeine (GO:0031000) | 3.45933018 |
111 | regulation of cofactor metabolic process (GO:0051193) | 3.45553132 |
112 | regulation of coenzyme metabolic process (GO:0051196) | 3.45553132 |
113 | positive regulation of cation channel activity (GO:2001259) | 3.45133321 |
114 | glycogen catabolic process (GO:0005980) | 3.43263491 |
115 | skeletal muscle tissue development (GO:0007519) | 3.42446681 |
116 | relaxation of muscle (GO:0090075) | 3.42380744 |
117 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.42090572 |
118 | detection of calcium ion (GO:0005513) | 3.41981569 |
119 | * muscle contraction (GO:0006936) | 3.41133177 |
120 | membrane repolarization during action potential (GO:0086011) | 3.40626435 |
121 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.40138844 |
122 | positive regulation of heart rate (GO:0010460) | 3.36682777 |
123 | glycogen biosynthetic process (GO:0005978) | 3.31574299 |
124 | glucan biosynthetic process (GO:0009250) | 3.31574299 |
125 | muscle cell cellular homeostasis (GO:0046716) | 3.29392343 |
126 | negative regulation of cardiac muscle hypertrophy (GO:0010614) | 3.28828255 |
127 | cardiac right ventricle morphogenesis (GO:0003215) | 3.27462486 |
128 | cardiac muscle cell proliferation (GO:0060038) | 3.26806111 |
129 | regulation of potassium ion transmembrane transporter activity (GO:1901016) | 3.25540127 |
130 | * muscle system process (GO:0003012) | 3.22902308 |
131 | carnitine transmembrane transport (GO:1902603) | 3.22653159 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 5.97806381 |
2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.62980611 |
3 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 4.44634871 |
4 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 4.44634871 |
5 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 4.32656497 |
6 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 4.18570568 |
7 | * MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 3.80347111 |
8 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 3.18416323 |
9 | * EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 3.16529508 |
10 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 3.15111155 |
11 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.92735622 |
12 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.87893370 |
13 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.86194702 |
14 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 2.71137293 |
15 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.62392177 |
16 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.29741595 |
17 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.97466247 |
18 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.96337453 |
19 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.95448351 |
20 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.92361679 |
21 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.92127115 |
22 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.82572726 |
23 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.77175066 |
24 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.76790815 |
25 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.75682087 |
26 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.72132482 |
27 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.71958846 |
28 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.66912871 |
29 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.64873939 |
30 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.59262049 |
31 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.54888537 |
32 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.53883725 |
33 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.53750534 |
34 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.50288177 |
35 | GATA1_22025678_ChIP-Seq_K562_Human | 1.48289976 |
36 | GATA1_19941826_ChIP-Seq_K562_Human | 1.45664358 |
37 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.41820463 |
38 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.41567303 |
39 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.41359392 |
40 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.38778928 |
41 | * ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.35648141 |
42 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.35584837 |
43 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.30715711 |
44 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.29488549 |
45 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.29473441 |
46 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.26830865 |
47 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.26313890 |
48 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.23110395 |
49 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.22256749 |
50 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.21419090 |
51 | * PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.21323433 |
52 | VDR_22108803_ChIP-Seq_LS180_Human | 1.19776497 |
53 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.18472056 |
54 | * CTCF_27219007_Chip-Seq_Bcells_Human | 1.16501809 |
55 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.14893353 |
56 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.14829238 |
57 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.10896092 |
58 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.09879493 |
59 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.09864928 |
60 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.08668649 |
61 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.06890584 |
62 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.05253152 |
63 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.04796169 |
64 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.03826429 |
65 | ATF3_27146783_Chip-Seq_COLON_Human | 1.03070148 |
66 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.03065855 |
67 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.02568639 |
68 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.01993234 |
69 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.00023706 |
70 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.98914853 |
71 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.97632746 |
72 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.97629286 |
73 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.97555417 |
74 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.97210924 |
75 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.96920505 |
76 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.96285306 |
77 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.95145860 |
78 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.95140523 |
79 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.93521968 |
80 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.93465249 |
81 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 0.93045103 |
82 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.92477070 |
83 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.92310081 |
84 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.91390331 |
85 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.91169245 |
86 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.91169245 |
87 | SPI1_23127762_ChIP-Seq_K562_Human | 0.88572099 |
88 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.88568879 |
89 | KDM2B_26808549_Chip-Seq_K562_Human | 0.87794102 |
90 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.87660351 |
91 | * TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.87429215 |
92 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.87345406 |
93 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.87170555 |
94 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.86135653 |
95 | GATA2_19941826_ChIP-Seq_K562_Human | 0.86032052 |
96 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.85381972 |
97 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.84356597 |
98 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.83691310 |
99 | CJUN_26792858_Chip-Seq_BT549_Human | 0.83503590 |
100 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.81975551 |
101 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.81920398 |
102 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.81838857 |
103 | * TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.81151556 |
104 | GF1_26923725_Chip-Seq_HPCs_Mouse | 0.81150821 |
105 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.80679067 |
106 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.79796188 |
107 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.79218462 |
108 | PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 0.78460381 |
109 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.78200558 |
110 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.77935644 |
111 | * TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 0.77124773 |
112 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.76488412 |
113 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.75488950 |
114 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.75482973 |
115 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.75277294 |
116 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.75277294 |
117 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.74793737 |
118 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.74236324 |
119 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.74058140 |
120 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.72870578 |
121 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.72454165 |
122 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.71782327 |
123 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.71731904 |
124 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.71478692 |
125 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.71300026 |
126 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.70710116 |
127 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.69942481 |
128 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.69801152 |
129 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.69581553 |
130 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.67774620 |
131 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.66942884 |
132 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.66676170 |
133 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.65650606 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0004084_abnormal_cardiac_muscle | 6.78780955 |
2 | MP0002837_dystrophic_cardiac_calcinosis | 6.73526846 |
3 | MP0004036_abnormal_muscle_relaxation | 4.76028829 |
4 | MP0004215_abnormal_myocardial_fiber | 4.72330770 |
5 | MP0000751_myopathy | 4.60167034 |
6 | MP0003646_muscle_fatigue | 4.16826949 |
7 | MP0005330_cardiomyopathy | 4.13871362 |
8 | MP0000749_muscle_degeneration | 3.73028491 |
9 | MP0002972_abnormal_cardiac_muscle | 3.53535621 |
10 | MP0008775_abnormal_heart_ventricle | 3.36517323 |
11 | MP0003137_abnormal_impulse_conducting | 3.17167147 |
12 | MP0004087_abnormal_muscle_fiber | 3.09216377 |
13 | MP0010630_abnormal_cardiac_muscle | 2.87551730 |
14 | MP0005620_abnormal_muscle_contractility | 2.84493046 |
15 | MP0006138_congestive_heart_failure | 2.80846274 |
16 | MP0001544_abnormal_cardiovascular_syste | 2.79059224 |
17 | MP0005385_cardiovascular_system_phenoty | 2.79059224 |
18 | MP0003828_pulmonary_edema | 2.69260996 |
19 | MP0000750_abnormal_muscle_regeneration | 2.44746532 |
20 | MP0002106_abnormal_muscle_physiology | 2.38032302 |
21 | MP0004085_abnormal_heartbeat | 2.33022658 |
22 | MP0004145_abnormal_muscle_electrophysio | 2.19615726 |
23 | MP0002269_muscular_atrophy | 2.05737913 |
24 | MP0003221_abnormal_cardiomyocyte_apopto | 2.03700012 |
25 | MP0002127_abnormal_cardiovascular_syste | 2.02675863 |
26 | MP0004484_altered_response_of | 2.00161658 |
27 | MP0005369_muscle_phenotype | 1.89136083 |
28 | MP0003567_abnormal_fetal_cardiomyocyte | 1.87372049 |
29 | MP0003950_abnormal_plasma_membrane | 1.85265183 |
30 | MP0004510_myositis | 1.81594049 |
31 | MP0004233_abnormal_muscle_weight | 1.77030544 |
32 | MP0000759_abnormal_skeletal_muscle | 1.71036216 |
33 | MP0000747_muscle_weakness | 1.70806081 |
34 | MP0004130_abnormal_muscle_cell | 1.66132746 |
35 | MP0005451_abnormal_body_composition | 1.63624854 |
36 | MP0003279_aneurysm | 1.47274005 |
37 | MP0000266_abnormal_heart_morphology | 1.28656812 |
38 | MP0002234_abnormal_pharynx_morphology | 1.28619813 |
39 | MP0010368_abnormal_lymphatic_system | 1.27937963 |
40 | MP0006036_abnormal_mitochondrial_physio | 1.25685140 |
41 | MP0003122_maternal_imprinting | 1.20253142 |
42 | MP0004272_abnormal_basement_membrane | 1.18938711 |
43 | MP0005623_abnormal_meninges_morphology | 1.13094936 |
44 | MP0003566_abnormal_cell_adhesion | 1.10552059 |
45 | MP0002332_abnormal_exercise_endurance | 1.06817902 |
46 | MP0003705_abnormal_hypodermis_morpholog | 0.94168705 |
47 | MP0005666_abnormal_adipose_tissue | 0.93164796 |
48 | MP0002128_abnormal_blood_circulation | 0.92727422 |
49 | MP0001661_extended_life_span | 0.89995953 |
50 | MP0000343_altered_response_to | 0.86819259 |
51 | MP0000767_abnormal_smooth_muscle | 0.84909013 |
52 | MP0005165_increased_susceptibility_to | 0.80864957 |
53 | MP0006035_abnormal_mitochondrial_morpho | 0.80090500 |
54 | MP0009384_cardiac_valve_regurgitation | 0.79665879 |
55 | MP0005670_abnormal_white_adipose | 0.75679150 |
56 | MP0000733_abnormal_muscle_development | 0.72548346 |
57 | MP0003123_paternal_imprinting | 0.72117032 |
58 | MP0000230_abnormal_systemic_arterial | 0.69683406 |
59 | MP0002925_abnormal_cardiovascular_devel | 0.69594375 |
60 | MP0009780_abnormal_chondrocyte_physiolo | 0.68905348 |
61 | MP0005377_hearing/vestibular/ear_phenot | 0.67211667 |
62 | MP0003878_abnormal_ear_physiology | 0.67211667 |
63 | MP0002088_abnormal_embryonic_growth/wei | 0.65315909 |
64 | MP0003984_embryonic_growth_retardation | 0.64551137 |
65 | MP0001879_abnormal_lymphatic_vessel | 0.63880816 |
66 | MP0008438_abnormal_cutaneous_collagen | 0.63809738 |
67 | MP0005375_adipose_tissue_phenotype | 0.61885502 |
68 | MP0004270_analgesia | 0.60857397 |
69 | MP0005266_abnormal_metabolism | 0.60786653 |
70 | MP0001784_abnormal_fluid_regulation | 0.58372827 |
71 | MP0002108_abnormal_muscle_morphology | 0.58192775 |
72 | MP0003045_fibrosis | 0.56079787 |
73 | MP0003806_abnormal_nucleotide_metabolis | 0.52750401 |
74 | MP0004185_abnormal_adipocyte_glucose | 0.52652380 |
75 | MP0001614_abnormal_blood_vessel | 0.51144539 |
76 | MP0003121_genomic_imprinting | 0.50068718 |
77 | MP0008569_lethality_at_weaning | 0.42632650 |
78 | MP0005380_embryogenesis_phenotype | 0.42252250 |
79 | MP0001672_abnormal_embryogenesis/_devel | 0.42252250 |
80 | MP0000013_abnormal_adipose_tissue | 0.41507425 |
81 | MP0005275_abnormal_skin_tensile | 0.40058284 |
82 | MP0002909_abnormal_adrenal_gland | 0.39406236 |
83 | MP0005187_abnormal_penis_morphology | 0.38380792 |
84 | MP0001299_abnormal_eye_distance/ | 0.38282556 |
85 | MP0002822_catalepsy | 0.37384879 |
86 | MP0002638_abnormal_pupillary_reflex | 0.36013659 |
87 | MP0003948_abnormal_gas_homeostasis | 0.35719749 |
88 | MP0005595_abnormal_vascular_smooth | 0.34162061 |
89 | MP0000003_abnormal_adipose_tissue | 0.33887440 |
90 | MP0003385_abnormal_body_wall | 0.32474363 |
91 | MP0009672_abnormal_birth_weight | 0.31379712 |
92 | MP0005319_abnormal_enzyme/_coenzyme | 0.30810982 |
93 | MP0002133_abnormal_respiratory_system | 0.29689413 |
94 | MP0005388_respiratory_system_phenotype | 0.29689413 |
95 | MP0005167_abnormal_blood-brain_barrier | 0.29249736 |
96 | MP0003115_abnormal_respiratory_system | 0.29116785 |
97 | MP0005376_homeostasis/metabolism_phenot | 0.28456488 |
98 | MP0001958_emphysema | 0.28375988 |
99 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.27181371 |
100 | MP0001727_abnormal_embryo_implantation | 0.26276831 |
101 | MP0001175_abnormal_lung_morphology | 0.25764762 |
102 | MP0005535_abnormal_body_temperature | 0.25266131 |
103 | MP0000762_abnormal_tongue_morphology | 0.25227897 |
104 | MP0005334_abnormal_fat_pad | 0.24944913 |
105 | MP0003935_abnormal_craniofacial_develop | 0.24339717 |
106 | MP0003656_abnormal_erythrocyte_physiolo | 0.23429413 |
107 | MP0001697_abnormal_embryo_size | 0.22851552 |
108 | MP0005386_behavior/neurological_phenoty | 0.22704422 |
109 | MP0004924_abnormal_behavior | 0.22704422 |
110 | MP0004147_increased_porphyrin_level | 0.22601736 |
111 | MP0004197_abnormal_fetal_growth/weight/ | 0.22594859 |
112 | MP0000428_abnormal_craniofacial_morphol | 0.22517183 |
113 | MP0000249_abnormal_blood_vessel | 0.22444373 |
114 | MP0002078_abnormal_glucose_homeostasis | 0.22412067 |
115 | MP0001984_abnormal_olfaction | 0.21411135 |
116 | MP0008961_abnormal_basal_metabolism | 0.21071743 |
117 | MP0002971_abnormal_brown_adipose | 0.20826513 |
118 | MP0003941_abnormal_skin_development | 0.20659826 |
119 | MP0002086_abnormal_extraembryonic_tissu | 0.19347028 |
120 | MP0000372_irregular_coat_pigmentation | 0.18850250 |
121 | MP0003879_abnormal_hair_cell | 0.18702082 |
122 | MP0008004_abnormal_stomach_pH | 0.18563828 |
123 | MP0005332_abnormal_amino_acid | 0.18297334 |
124 | MP0009115_abnormal_fat_cell | 0.18159573 |
125 | MP0008874_decreased_physiological_sensi | 0.16607510 |
126 | MP0004043_abnormal_pH_regulation | 0.16216492 |
127 | MP0005166_decreased_susceptibility_to | 0.16180395 |
128 | MP0002896_abnormal_bone_mineralization | 0.15419544 |
129 | MP0000579_abnormal_nail_morphology | 0.15204348 |
130 | MP0005452_abnormal_adipose_tissue | 0.14809468 |
Rank | Gene Set | Z-score |
---|---|---|
1 | * Sudden death (HP:0001699) | 8.82197786 |
2 | Ventricular tachycardia (HP:0004756) | 7.34653589 |
3 | Atrial fibrillation (HP:0005110) | 6.67629013 |
4 | Primary atrial arrhythmia (HP:0001692) | 6.24208607 |
5 | Calf muscle hypertrophy (HP:0008981) | 6.23733962 |
6 | Exercise-induced muscle cramps (HP:0003710) | 6.10129667 |
7 | Supraventricular tachycardia (HP:0004755) | 6.03988937 |
8 | Supraventricular arrhythmia (HP:0005115) | 5.95763801 |
9 | * Lipoatrophy (HP:0100578) | 5.93424874 |
10 | Muscle fiber splitting (HP:0003555) | 5.92050572 |
11 | Muscle hypertrophy of the lower extremities (HP:0008968) | 5.66075436 |
12 | * Subaortic stenosis (HP:0001682) | 5.65439989 |
13 | * Abnormality of the left ventricular outflow tract (HP:0011103) | 5.65439989 |
14 | Exercise-induced myalgia (HP:0003738) | 5.56722210 |
15 | Syncope (HP:0001279) | 5.30815861 |
16 | Right ventricular cardiomyopathy (HP:0011663) | 5.20813045 |
17 | Hyporeflexia of lower limbs (HP:0002600) | 5.16332202 |
18 | Prolonged QT interval (HP:0001657) | 5.13459520 |
19 | * Abnormality of the calf musculature (HP:0001430) | 5.00783015 |
20 | * Dilated cardiomyopathy (HP:0001644) | 4.73743803 |
21 | Palpitations (HP:0001962) | 4.61276078 |
22 | Ventricular fibrillation (HP:0001663) | 4.60435354 |
23 | * Ventricular arrhythmia (HP:0004308) | 4.48996599 |
24 | Myopathic facies (HP:0002058) | 4.37492815 |
25 | Distal arthrogryposis (HP:0005684) | 4.25353851 |
26 | Bundle branch block (HP:0011710) | 4.18174155 |
27 | * EMG: myopathic abnormalities (HP:0003458) | 4.05413145 |
28 | Myoglobinuria (HP:0002913) | 4.00845440 |
29 | Abnormal EKG (HP:0003115) | 3.79665171 |
30 | Atrioventricular block (HP:0001678) | 3.72804668 |
31 | Heart block (HP:0012722) | 3.64921101 |
32 | Increased connective tissue (HP:0009025) | 3.58250684 |
33 | Round ear (HP:0100830) | 3.56862444 |
34 | * Centrally nucleated skeletal muscle fibers (HP:0003687) | 3.55192124 |
35 | Abnormal atrioventricular conduction (HP:0005150) | 3.43673276 |
36 | Left ventricular hypertrophy (HP:0001712) | 3.34113668 |
37 | Myotonia (HP:0002486) | 3.30981083 |
38 | * Asymmetric septal hypertrophy (HP:0001670) | 3.27419313 |
39 | Ulnar deviation of the wrist (HP:0003049) | 3.23981886 |
40 | Muscle fiber inclusion bodies (HP:0100299) | 3.15612350 |
41 | Frequent falls (HP:0002359) | 3.13802961 |
42 | Rhabdomyolysis (HP:0003201) | 3.09603206 |
43 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 3.06037412 |
44 | Congenital malformation of the right heart (HP:0011723) | 3.01044320 |
45 | Double outlet right ventricle (HP:0001719) | 3.01044320 |
46 | Difficulty running (HP:0009046) | 2.89421649 |
47 | * Palmoplantar keratoderma (HP:0000982) | 2.85500763 |
48 | Difficulty climbing stairs (HP:0003551) | 2.79347928 |
49 | Calcaneovalgus deformity (HP:0001848) | 2.74840639 |
50 | * Type 1 muscle fiber predominance (HP:0003803) | 2.60118257 |
51 | Bulbar palsy (HP:0001283) | 2.54961827 |
52 | Absent phalangeal crease (HP:0006109) | 2.53191180 |
53 | Hypoplastic left heart (HP:0004383) | 2.44565157 |
54 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.41313991 |
55 | Deformed tarsal bones (HP:0008119) | 2.41059881 |
56 | Nemaline bodies (HP:0003798) | 2.38957586 |
57 | Conjunctival hamartoma (HP:0100780) | 2.36534265 |
58 | Pulmonary artery stenosis (HP:0004415) | 2.36093659 |
59 | * Neck muscle weakness (HP:0000467) | 2.36056826 |
60 | Patent foramen ovale (HP:0001655) | 2.34720885 |
61 | Acute necrotizing encephalopathy (HP:0006965) | 2.33638455 |
62 | Hepatic necrosis (HP:0002605) | 2.31479610 |
63 | Muscle stiffness (HP:0003552) | 2.29119800 |
64 | Distal lower limb muscle weakness (HP:0009053) | 2.27329290 |
65 | Neoplasm of the adrenal gland (HP:0100631) | 2.27118574 |
66 | Limb-girdle muscle atrophy (HP:0003797) | 2.26113451 |
67 | Increased variability in muscle fiber diameter (HP:0003557) | 2.24132862 |
68 | Malignant hyperthermia (HP:0002047) | 2.23947044 |
69 | Lower limb amyotrophy (HP:0007210) | 2.23595825 |
70 | * Sudden cardiac death (HP:0001645) | 2.23170949 |
71 | Weak cry (HP:0001612) | 2.23068480 |
72 | Proximal amyotrophy (HP:0007126) | 2.22949158 |
73 | Lymphangioma (HP:0100764) | 2.21239072 |
74 | Rimmed vacuoles (HP:0003805) | 2.18238682 |
75 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.15009942 |
76 | Ketoacidosis (HP:0001993) | 2.13185459 |
77 | Hip contracture (HP:0003273) | 2.09695640 |
78 | Areflexia of lower limbs (HP:0002522) | 2.09342988 |
79 | Progressive muscle weakness (HP:0003323) | 2.08253095 |
80 | Pheochromocytoma (HP:0002666) | 2.07046980 |
81 | * Congestive heart failure (HP:0001635) | 2.06135902 |
82 | Abnormal finger flexion creases (HP:0006143) | 2.04858153 |
83 | Hepatocellular necrosis (HP:0001404) | 2.01828459 |
84 | Foot dorsiflexor weakness (HP:0009027) | 2.01765650 |
85 | * Scapular winging (HP:0003691) | 2.00978706 |
86 | Hypoglycemic coma (HP:0001325) | 2.00097120 |
87 | Distal lower limb amyotrophy (HP:0008944) | 1.97209030 |
88 | Acute encephalopathy (HP:0006846) | 1.93600653 |
89 | Mitochondrial inheritance (HP:0001427) | 1.91901444 |
90 | Preauricular pit (HP:0004467) | 1.91738862 |
91 | Periauricular skin pits (HP:0100277) | 1.91738862 |
92 | Exercise intolerance (HP:0003546) | 1.91548189 |
93 | * Abnormality of the foot musculature (HP:0001436) | 1.91429809 |
94 | Multiple enchondromatosis (HP:0005701) | 1.90495811 |
95 | Hamartoma of the eye (HP:0010568) | 1.89405273 |
96 | Steppage gait (HP:0003376) | 1.88897186 |
97 | Hypoplastic heart (HP:0001961) | 1.88566098 |
98 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.86872169 |
99 | Slender build (HP:0001533) | 1.86260724 |
100 | Progressive macrocephaly (HP:0004481) | 1.85434805 |
101 | Increased intramyocellular lipid droplets (HP:0012240) | 1.84539541 |
102 | Dysmetric saccades (HP:0000641) | 1.84143142 |
103 | Increased CSF lactate (HP:0002490) | 1.83529395 |
104 | Gowers sign (HP:0003391) | 1.81712038 |
105 | Neuroendocrine neoplasm (HP:0100634) | 1.79702766 |
106 | Fatigable weakness (HP:0003473) | 1.79515441 |
107 | Abnormality of the neuromuscular junction (HP:0003398) | 1.79515441 |
108 | * Ragged-red muscle fibers (HP:0003200) | 1.78981218 |
109 | Increased muscle lipid content (HP:0009058) | 1.77628729 |
110 | * Mildly elevated creatine phosphokinase (HP:0008180) | 1.76741130 |
111 | Muscular dystrophy (HP:0003560) | 1.75457253 |
112 | Fetal akinesia sequence (HP:0001989) | 1.73580166 |
113 | Hyperkalemia (HP:0002153) | 1.72360326 |
114 | Cerebral edema (HP:0002181) | 1.71894312 |
115 | * Generalized muscle weakness (HP:0003324) | 1.70747994 |
116 | Testicular atrophy (HP:0000029) | 1.70690147 |
117 | Dicarboxylic aciduria (HP:0003215) | 1.70305632 |
118 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.70305632 |
119 | Bradycardia (HP:0001662) | 1.68855676 |
120 | * EMG: neuropathic changes (HP:0003445) | 1.68225511 |
121 | * Abnormality of the shoulder girdle musculature (HP:0001435) | 1.67768723 |
122 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.66452332 |
123 | Diaphragmatic weakness (HP:0009113) | 1.65438740 |
124 | Spinal rigidity (HP:0003306) | 1.65353922 |
125 | Neoplasm of head and neck (HP:0012288) | 1.64818136 |
126 | Limb-girdle muscle weakness (HP:0003325) | 1.64138373 |
127 | * Waddling gait (HP:0002515) | 1.60898356 |
128 | Facial diplegia (HP:0001349) | 1.52173886 |
129 | Abnormality of the calcaneus (HP:0008364) | 1.48922388 |
130 | Increased serum pyruvate (HP:0003542) | 1.47838928 |
131 | Limited hip movement (HP:0008800) | 1.46619698 |
Rank | Gene Set | Z-score |
---|---|---|
1 | OBSCN | 6.44536485 |
2 | MYLK | 4.55791326 |
3 | PKN2 | 4.43127774 |
4 | TTN | 4.29096582 |
5 | DMPK | 3.59165931 |
6 | LMTK2 | 3.54097991 |
7 | PHKG1 | 3.11794620 |
8 | PHKG2 | 3.11794620 |
9 | STK24 | 3.11365787 |
10 | TRIB3 | 2.89142018 |
11 | PDK4 | 2.45477657 |
12 | PDK3 | 2.45477657 |
13 | PIK3CA | 2.43833663 |
14 | TIE1 | 2.34141320 |
15 | NEK1 | 2.32066318 |
16 | CDC42BPA | 1.97932589 |
17 | MUSK | 1.97282583 |
18 | ILK | 1.81409814 |
19 | BCKDK | 1.47718858 |
20 | ZAK | 1.41391397 |
21 | DAPK3 | 1.38601765 |
22 | FLT3 | 1.37440414 |
23 | ROCK1 | 1.37390354 |
24 | MARK1 | 1.36874734 |
25 | PDK2 | 1.30827857 |
26 | PRKD1 | 1.27474178 |
27 | STK38L | 1.25827997 |
28 | PAK3 | 1.25450453 |
29 | MAP3K5 | 1.14484340 |
30 | WNK4 | 1.12647283 |
31 | RIPK1 | 1.08362628 |
32 | PTK2B | 1.04131169 |
33 | TRPM7 | 1.03626293 |
34 | MAPK12 | 1.02864389 |
35 | CAMK2D | 1.01848753 |
36 | MAP3K7 | 1.01257269 |
37 | STK4 | 0.99428192 |
38 | MAPKAPK3 | 0.94679103 |
39 | PINK1 | 0.89970907 |
40 | MAP3K10 | 0.85592921 |
41 | MAP3K6 | 0.81737977 |
42 | EEF2K | 0.79873866 |
43 | PRKAA1 | 0.73932065 |
44 | STK38 | 0.72060295 |
45 | MAP3K3 | 0.71914156 |
46 | PRKAA2 | 0.71397795 |
47 | ROCK2 | 0.70487897 |
48 | MAP2K4 | 0.69573398 |
49 | INSRR | 0.69157183 |
50 | PDGFRA | 0.66096304 |
51 | KDR | 0.65180161 |
52 | PKN1 | 0.65070109 |
53 | MAPK4 | 0.61911710 |
54 | CAMK1 | 0.60128750 |
55 | LIMK1 | 0.58605212 |
56 | ICK | 0.58378821 |
57 | MAP2K3 | 0.57466234 |
58 | TGFBR2 | 0.56614116 |
59 | EPHA3 | 0.56500958 |
60 | CAMK2B | 0.55819573 |
61 | STK39 | 0.55699165 |
62 | WNK1 | 0.55095481 |
63 | PTK6 | 0.54433209 |
64 | CAMK4 | 0.53954504 |
65 | DYRK1B | 0.53241875 |
66 | SIK1 | 0.52314795 |
67 | CAMK2A | 0.51478798 |
68 | RPS6KL1 | 0.51236226 |
69 | RPS6KC1 | 0.51236226 |
70 | MOS | 0.50179989 |
71 | MAP2K1 | 0.48520251 |
72 | PRKACB | 0.48268878 |
73 | PRKD3 | 0.47025709 |
74 | MAP2K6 | 0.45169408 |
75 | AKT2 | 0.43800171 |
76 | KSR2 | 0.43524204 |
77 | GRK7 | 0.43165989 |
78 | UHMK1 | 0.43165180 |
79 | PRKCE | 0.42419299 |
80 | ERBB3 | 0.42205131 |
81 | CCNB1 | 0.42131845 |
82 | RPS6KA6 | 0.41942061 |
83 | EPHB2 | 0.40998789 |
84 | SGK3 | 0.36882105 |
85 | EPHB1 | 0.34785593 |
86 | PRKACA | 0.34274485 |
87 | PAK2 | 0.34188943 |
88 | PIK3CG | 0.33214290 |
89 | PRKG2 | 0.32826239 |
90 | PRKACG | 0.31477245 |
91 | LRRK2 | 0.29627762 |
92 | RPS6KA3 | 0.29614878 |
93 | LATS2 | 0.29443069 |
94 | MTOR | 0.28854357 |
95 | SGK2 | 0.26237329 |
96 | MAPK10 | 0.23729703 |
97 | MAP3K13 | 0.22517840 |
98 | PDK1 | 0.22495581 |
99 | PDPK1 | 0.21563539 |
100 | FGFR1 | 0.21327505 |
101 | RET | 0.21064282 |
102 | PRPF4B | 0.21003552 |
103 | TESK1 | 0.20528023 |
104 | PRKG1 | 0.19657071 |
105 | RPS6KA2 | 0.19044454 |
106 | TGFBR1 | 0.18846684 |
107 | PRKCH | 0.18630264 |
108 | LATS1 | 0.18427132 |
109 | CDK4 | 0.18352641 |
110 | FER | 0.18349559 |
111 | CAMK2G | 0.18142481 |
112 | MARK2 | 0.17381669 |
113 | MARK3 | 0.17219416 |
114 | SGK1 | 0.16860106 |
115 | MAPK11 | 0.16783487 |
116 | ZAP70 | 0.16598990 |
117 | NLK | 0.16246301 |
118 | MAPKAPK2 | 0.16183259 |
119 | NME1 | 0.15310748 |
120 | MAP3K1 | 0.14610014 |
121 | RPS6KA1 | 0.14339137 |
122 | TBK1 | 0.13635213 |
123 | RPS6KB2 | 0.11683976 |
124 | STK11 | 0.11659158 |
125 | SGK223 | 0.11484688 |
126 | SGK494 | 0.11484688 |
127 | STK3 | 0.11447724 |
128 | NEK9 | 0.11159455 |
129 | PRKCQ | 0.10998817 |
130 | MAPK7 | 0.10670883 |
131 | ITK | 0.10475408 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 5.78706722 |
2 | * Cardiac muscle contraction_Homo sapiens_hsa04260 | 5.04419502 |
3 | * Dilated cardiomyopathy_Homo sapiens_hsa05414 | 4.48685556 |
4 | * Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 4.43587514 |
5 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 4.32488577 |
6 | Parkinsons disease_Homo sapiens_hsa05012 | 3.02550118 |
7 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.97488371 |
8 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.79981801 |
9 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 2.78922087 |
10 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.39419391 |
11 | Carbon metabolism_Homo sapiens_hsa01200 | 2.37689225 |
12 | * Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 2.28706155 |
13 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.27983469 |
14 | Alzheimers disease_Homo sapiens_hsa05010 | 2.14359164 |
15 | Huntingtons disease_Homo sapiens_hsa05016 | 1.88957443 |
16 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.88248767 |
17 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.63806972 |
18 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.57706236 |
19 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.50044078 |
20 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.49798806 |
21 | * Viral myocarditis_Homo sapiens_hsa05416 | 1.38293869 |
22 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.37440379 |
23 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.34402541 |
24 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.21670218 |
25 | * cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.19418122 |
26 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.10582815 |
27 | Insulin resistance_Homo sapiens_hsa04931 | 1.09753057 |
28 | Focal adhesion_Homo sapiens_hsa04510 | 1.08554975 |
29 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.05406839 |
30 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.96838172 |
31 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.93472606 |
32 | * Tight junction_Homo sapiens_hsa04530 | 0.90966321 |
33 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.88636609 |
34 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.86685785 |
35 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.83750512 |
36 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.83376289 |
37 | Lysine degradation_Homo sapiens_hsa00310 | 0.81915809 |
38 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.81751282 |
39 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.77525102 |
40 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.76231017 |
41 | Galactose metabolism_Homo sapiens_hsa00052 | 0.74884640 |
42 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.74248468 |
43 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.73507544 |
44 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.73348020 |
45 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.66010967 |
46 | Adherens junction_Homo sapiens_hsa04520 | 0.65044316 |
47 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.62647430 |
48 | Amoebiasis_Homo sapiens_hsa05146 | 0.61777841 |
49 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.61622732 |
50 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.60572187 |
51 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.60157301 |
52 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.56084830 |
53 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.55480695 |
54 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.50508228 |
55 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.50335813 |
56 | Long-term potentiation_Homo sapiens_hsa04720 | 0.50209758 |
57 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.49693586 |
58 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.49670199 |
59 | Renin secretion_Homo sapiens_hsa04924 | 0.48861166 |
60 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.48823397 |
61 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.47867705 |
62 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.47678801 |
63 | Insulin secretion_Homo sapiens_hsa04911 | 0.46337167 |
64 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.43898429 |
65 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.43530663 |
66 | Salivary secretion_Homo sapiens_hsa04970 | 0.41919164 |
67 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.41688186 |
68 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.40543162 |
69 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.39873165 |
70 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.38889544 |
71 | Circadian entrainment_Homo sapiens_hsa04713 | 0.38619988 |
72 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.38190610 |
73 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.34491874 |
74 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.33624639 |
75 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.32096834 |
76 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.30771601 |
77 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.28845062 |
78 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.26540244 |
79 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.25822192 |
80 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.25068872 |
81 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.24309980 |
82 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.24135065 |
83 | Platelet activation_Homo sapiens_hsa04611 | 0.24133525 |
84 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.23771766 |
85 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.23327189 |
86 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.21645092 |
87 | GABAergic synapse_Homo sapiens_hsa04727 | 0.21425871 |
88 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.20932933 |
89 | Olfactory transduction_Homo sapiens_hsa04740 | 0.19383352 |
90 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.18638637 |
91 | Sulfur relay system_Homo sapiens_hsa04122 | 0.18364429 |
92 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.17986162 |
93 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.17887814 |
94 | Circadian rhythm_Homo sapiens_hsa04710 | 0.16585863 |
95 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.16216258 |
96 | Gap junction_Homo sapiens_hsa04540 | 0.14874665 |
97 | Melanogenesis_Homo sapiens_hsa04916 | 0.14727005 |
98 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.14682546 |
99 | Prion diseases_Homo sapiens_hsa05020 | 0.14659477 |
100 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.14507252 |
101 | Bile secretion_Homo sapiens_hsa04976 | 0.13364648 |
102 | Metabolic pathways_Homo sapiens_hsa01100 | 0.12446567 |
103 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.12389208 |
104 | Peroxisome_Homo sapiens_hsa04146 | 0.12296218 |
105 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.12197277 |
106 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.11176858 |
107 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.11034492 |
108 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.10866626 |
109 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.10250421 |
110 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.09619954 |
111 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.08221521 |
112 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.08132447 |
113 | Morphine addiction_Homo sapiens_hsa05032 | 0.07825062 |
114 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.06543358 |
115 | Taste transduction_Homo sapiens_hsa04742 | 0.06393233 |
116 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.06305119 |
117 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.04602106 |
118 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.03374180 |